دورية أكاديمية

Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study

التفاصيل البيبلوغرافية
العنوان: Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
المؤلفون: Leighl, Natasha B *, Hellmann, Matthew D, Hui, Rina, Carcereny, Enric, Felip, Enriqueta, Ahn, Myung-Ju, Eder, Joseph Paul, Balmanoukian, Ani S, Aggarwal, Charu, Horn, Leora, Patnaik, Amita, Gubens, Matthew, Ramalingam, Suresh S, Lubiniecki, Gregory M, Zhang, Jin, Piperdi, Bilal, Garon, Edward B
المصدر: In The Lancet Respiratory Medicine April 2019 7(4):347-357
قاعدة البيانات: ScienceDirect
الوصف
تدمد:22132600
DOI:10.1016/S2213-2600(18)30500-9